Prof. Kevin Ault, Gynaecologist, from the Emory University School of Medicine, University of Iowa, USA has present the results of the last Study’s conclusions are Incredible and it’s true; he told about a vaccine, that is 100 % effective in preventing the most common types of Cervical cancer linked to HPV (D3-to see).
The HPV infections are sexually transmitted diseases which prepare the way for cervical cancer. We can protect the women against the most Carcinogenic subtypes (6, 11, 16 and 18 of HPV) which are the cause of More than 70 % of cervical cancers.
With optimistic results of the Future II study, 20541 Women from Europe, America and Asia, between the ages of 16 and 26 years old, was involved in this extensive project. Of course, the methodological rules, as a blind Study compared the quadrivalent vaccine do a placebo. The Vaccine protected the young women completely against precancerous Lesions (medium - or high-grad) of the Cervix related to HPV 16 and 18. The protection result was 100 % of cases! The sid-effects comes with an extremely low number. If we see the large number of cases in this study, the results should be the same if vaccination is made Available to the public.
We should not forget - the Cervical Cancer is the second leading cancer in Young women and accounts for 11 % of Cancers in all women! When the Women has a common genital Infection with the human papillomavirus (HPV) and its can result in the appearance of precancerous lesions of the Cervix Mucous membrane. For instance, we know that the connection between HPV infection and cervical cancer is much stronger than that between smoking and lung cancer.
How the researcher has got these results? With this new quadrivalent vaccine for cervical cancer, the most oncogenic subtypes of HPV can now be whipped out. One of the first steps is vaccinating adolescents (D3-”Chronical”) Before they come into contact with the virus; - Results - No virus, no Lesions - no cancer! Prevention - the essential part of the combating Cervical Cancer.
The most oncogenic subtypes of HPV can now be wiped out thanks to this new quadrivalent vaccine. The first step is vaccinating adolescents (D3 - “Chronical”) before they come into contact with the virus; this is a turning point in the fight against cancer. It is a major tool in the prevention of precancerous lesions in the cervix. No virus, no lesions - and if there are no lesions, that means no cancer. Prevention is an essential part of the equation when it comes to combating cervical cancer - that’s why oncologists are so excited about the new Vaccine.
A study conducted with more than 20,000 women has shown the absolute effectiveness of a vaccine in the prevention of cervical cancer due to the most common types of human papillomavirus (HPV). Oncologists are enthusiastic. It is a rare thing to hear physicians - and even more so, oncologists -get excited to the point of speaking of a “historical breakthrough” after hearing a presentation from a colleague.
Prof. Thomas Turz, Director of the Institute Gustave Roussy at the ECCO conference has say - It is a rare thing to hear physicians - and even more so, oncologists -get excited to the point of speaking of a “historical breakthrough” after hearing a presentation from a colleague. The Oncologists are enthusiastic.
Subscribe to:
Post Comments (Atom)
If you are smart or have a strong stomach, you do a search for the causes, effects, symptoms, treatments, outcomes, support groups, and residual fallout of cervical cancer. You might find statistics: 500,000 cases worldwide; 300,000 die. 10,370 in US will be diagnosed with it; 3,710 will die. Mortality rates have declined by 50% over the last three decades.
Muna wa Wanjiru has been researching and reporting on health for years. If You Have Any Comments Or Views That You Would Wish To Share With Our Readers on Cervical Cancer, Post Them On His Blog HERE CERVICAL CANCER